Reduced atrial angiotensin receptor type 1 mRNA content in end-stage human heart failure : assessment by a novel quantitative PCR-ELISA technique
- Author
- BAUER, P1 ; REGITZ-ZAGROSEK, V1 ; HOFMEISTER, J; LOKIES, J1 ; ROLFS, A; HILDEBRANDT, A. G; HETZER, R; FLECK, E1
[1] Innere Medizin/Kardiologie, Virchow Klinikum, Humboldt Universität, Augustenburger Platz, 13353 Berlin, Germany - Conference title
- Molecular targets for drug development
- Conference name
- KBF Symposium (Braunschweig 1996-09-04)
- Author (monograph)
- Verbund Klinisch-Biomedizinische Forschung, Germany (Funder/Sponsor)
Gesellschaft für Biotechnologische Forschung, Germany (Funder/Sponsor) - Source
Journal of molecular medicine (Berlin. Print). 1996, Vol 74, Num 8, pp 447-454 ; ref : 23 ref
- ISSN
- 0946-2716
- Scientific domain
- General medicine general surgery
- Publisher
- Springer, Berlin
- Publication country
- Germany
- Document type
- Conference Paper
- Language
- English
- Keyword (fr)
- Analyse quantitative Angiotensine II Exploration Homme Insuffisance cardiaque Oreillette RNA messager Réaction chaîne polymérase Récepteur biologique Stade terminal Technique ELISA Technique associée Appareil circulatoire pathologie Biologie moléculaire Cardiopathie Hormone peptide Système renin angiotensine
- Keyword (en)
- Quantitative analysis Angiotensin II Exploration Human Heart failure Atrium Messenger RNA Polymerase chain reaction Biological receptor Terminal stage ELISA assay Associated technique Cardiovascular disease Molecular biology Heart disease Peptide hormone Renin angiotensin system
- Keyword (es)
- Análisis cuantitativo Angiotensina II Exploración Hombre Insuficiencia cardíaca Orejuela RNA mensajero Reacción cadena polimerasa Receptor biológico Estadio terminal Técnica ELISA Técnica asociada Aparato circulatorio patología Biología molecular Cardiopatía Hormona péptido Sistema renin angiotensina
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12A Heart / 002B12A01 Heart failure, cardiogenic pulmonary edema, cardiac enlargement
- Discipline
- Cardiology. Circulatory system
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 3264155
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1007/BF00217520 
https://dx.doi.org/10.1007/BF00217520
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1007\/BF00217520\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Reduced atrial angiotensin receptor type 1 mRNA content in end-stage human heart failure : assessment by a novel quantitative PCR-ELISA technique\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of molecular medicine (Berlin. Print)\";s:9:\"\u0000*\u0000stitle\";s:27:\"J. mol. med. (Berl., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"74\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"447\";s:8:\"\u0000*\u0000epage\";s:3:\"454\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0946-2716\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BAUER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:18:\"REGITZ-ZAGROSEK, V\";i:1;s:13:\"HOFMEISTER, J\";i:2;s:9:\"LOKIES, J\";i:3;s:8:\"ROLFS, A\";i:4;s:17:\"HILDEBRANDT, A. G\";i:5;s:9:\"HETZER, R\";i:6;s:8:\"FLECK, E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:38:\"Molecular targets for drug development\";s:8:\"\u0000*\u0000title\";s:145:\"Reduced atrial angiotensin receptor type 1 mRNA content in end-stage human heart failure : assessment by a novel quantitative PCR-ELISA technique\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1007\/BF00217520\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Reduced atrial angiotensin receptor type 1 mRNA content in end-stage human heart failure : assessment by a novel quantitative PCR-ELISA technique\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of molecular medicine (Berlin. Print)\";s:9:\"\u0000*\u0000stitle\";s:27:\"J. mol. med. (Berl., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"74\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"447\";s:8:\"\u0000*\u0000epage\";s:3:\"454\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0946-2716\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BAUER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:18:\"REGITZ-ZAGROSEK, V\";i:1;s:13:\"HOFMEISTER, J\";i:2;s:9:\"LOKIES, J\";i:3;s:8:\"ROLFS, A\";i:4;s:17:\"HILDEBRANDT, A. G\";i:5;s:9:\"HETZER, R\";i:6;s:8:\"FLECK, E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:38:\"Molecular targets for drug development\";s:8:\"\u0000*\u0000title\";s:145:\"Reduced atrial angiotensin receptor type 1 mRNA content in end-stage human heart failure : assessment by a novel quantitative PCR-ELISA technique\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:18:\"10.1007\/BF00217520\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1007\/BF00217520\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Reduced atrial angiotensin receptor type 1 mRNA content in end-stage human heart failure : assessment by a novel quantitative PCR-ELISA technique\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of molecular medicine (Berlin. Print)\";s:9:\"\u0000*\u0000stitle\";s:27:\"J. mol. med. (Berl., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"74\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"447\";s:8:\"\u0000*\u0000epage\";s:3:\"454\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0946-2716\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BAUER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:18:\"REGITZ-ZAGROSEK, V\";i:1;s:13:\"HOFMEISTER, J\";i:2;s:9:\"LOKIES, J\";i:3;s:8:\"ROLFS, A\";i:4;s:17:\"HILDEBRANDT, A. G\";i:5;s:9:\"HETZER, R\";i:6;s:8:\"FLECK, E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:38:\"Molecular targets for drug development\";s:8:\"\u0000*\u0000title\";s:145:\"Reduced atrial angiotensin receptor type 1 mRNA content in end-stage human heart failure : assessment by a novel quantitative PCR-ELISA technique\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1007\/BF00217520\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Reduced atrial angiotensin receptor type 1 mRNA content in end-stage human heart failure : assessment by a novel quantitative PCR-ELISA technique\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of molecular medicine (Berlin. Print)\";s:9:\"\u0000*\u0000stitle\";s:27:\"J. mol. med. (Berl., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"74\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"447\";s:8:\"\u0000*\u0000epage\";s:3:\"454\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0946-2716\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BAUER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:18:\"REGITZ-ZAGROSEK, V\";i:1;s:13:\"HOFMEISTER, J\";i:2;s:9:\"LOKIES, J\";i:3;s:8:\"ROLFS, A\";i:4;s:17:\"HILDEBRANDT, A. G\";i:5;s:9:\"HETZER, R\";i:6;s:8:\"FLECK, E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:38:\"Molecular targets for drug development\";s:8:\"\u0000*\u0000title\";s:145:\"Reduced atrial angiotensin receptor type 1 mRNA content in end-stage human heart failure : assessment by a novel quantitative PCR-ELISA technique\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1007\/BF00217520\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Reduced atrial angiotensin receptor type 1 mRNA content in end-stage human heart failure : assessment by a novel quantitative PCR-ELISA technique\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of molecular medicine (Berlin. Print)\";s:9:\"\u0000*\u0000stitle\";s:27:\"J. mol. med. (Berl., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"74\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"447\";s:8:\"\u0000*\u0000epage\";s:3:\"454\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0946-2716\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BAUER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:18:\"REGITZ-ZAGROSEK, V\";i:1;s:13:\"HOFMEISTER, J\";i:2;s:9:\"LOKIES, J\";i:3;s:8:\"ROLFS, A\";i:4;s:17:\"HILDEBRANDT, A. G\";i:5;s:9:\"HETZER, R\";i:6;s:8:\"FLECK, E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:38:\"Molecular targets for drug development\";s:8:\"\u0000*\u0000title\";s:145:\"Reduced atrial angiotensin receptor type 1 mRNA content in end-stage human heart failure : assessment by a novel quantitative PCR-ELISA technique\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
